Skip to content

Effectiveness and Safety of Jianlisu ® sugammadex on the Reversal of Postoperative Residual Neuromuscular Blockade in Pediatric Patients

Effectiveness and Safety of Jianlisu ® sugammadex on the Reversal of Postoperative Residual Neuromuscular Blockade in Pediatric Patients

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097055
Enrollment
Unknown
Registered
2025-02-11
Start date
2024-05-23
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Residual Neuromuscular Blockade in Pediatric Patients

Interventions

Jianlisu sugammadex:Use of jianlisu sugammadex for postoprerative residual neuromuscular blockade
Original sugammadex:Use of original sugammadex for postoprerative residual neuromuscular blockade

Sponsors

Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria: 1. aged 2 to 17 years old; 2. No gender limit, 3. ASA ? to ?, 4. undergoing elective laparoscopic inguinal hernia repair with general anesthesia, 5. The guardian of the child signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients aged less than 2 years or more than 17 years old, 2. with a history of allergy to the test drug, 3. ASA >=? , 4. The patient was complicated with difficult airway, 5. The patient was complicated with neuromuscular diseases or other congenital diseases, 6. severe liver or kidney function damage, 7. long-term use of drugs affecting neuromuscular transmission, 8. patients or their guardians who refuse to participate in the study.

Design outcomes

Primary

MeasureTime frame
recovery time of TOFR from 0.2 to 0.9;

Secondary

MeasureTime frame
Extubation time;PACU time;

Countries

China

Contacts

Public ContactZheng Jijian

Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University of Medicine

zhengjijian626@sina.com+86 21 3862 6161

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026